- Home
- PROF
as 12-27-2024 4:00pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 215.6M | IPO Year: | N/A |
| Target Price: | $11.40 | AVG Volume (30 days): | 116.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.88 - $11.42 | Next Earning Date: | 11-07-2024 |
| Revenue: | $8,984,000 | Revenue Growth: | 39.35% |
| Revenue Growth (this year): | 56.61% | Revenue Growth (next year): | 160.87% |
Latest Profound Medical Corp. News
PROF Breaking Stock News: Dive into PROF Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock
GlobeNewswire
18 days ago
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
CNW Group
22 days ago
Canadian Investment Regulatory Organization Trade Resumption - PRN
CNW Group
22 days ago
Canadian Investment Regulatory Organization Trading Halt - PRN
GlobeNewswire
22 days ago
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
GlobeNewswire
23 days ago
Profound Medical Announces Proposed Public Offering of Common Shares
TipRanks
25 days ago
Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement
GlobeNewswire
a month ago
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
Compare PROF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.